Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Times DC.
Press releases published on June 3, 2025

Western New England Bancorp, Inc. Announces Completion of 2024 Repurchase Plan
WESTFIELD, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Western New England Bancorp, Inc. (the “Company” or “WNEB”) (NasdaqGS: WNEB), the holding company for Westfield Bank (the “Bank”), announced that on May 30, 2025, the Company completed all repurchases …

DBV Technologies publie un amendement à son Document d’enregistrement universel 2024
Châtillon, France, le 3 juin 2025 DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), (la « Société »), société biopharmaceutique en …

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company …

Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa
ORION OYJ LEHDISTÖTIEDOTE 3.6.2025 klo 23.30 Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa Darolutamidi on ensimmäinen ja ainoa androgeenireseptorin …

Outset Medical Appoints Renee Gaeta as Chief Financial Officer
SAN JOSE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of Renee …

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor ( …

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …

Ingersoll Rand to Participate in Upcoming Investor Conference
DAVIDSON, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vik Kini, chief financial officer, and Matthew Fort, vice …

Beyond Oil Issues Clarification Regarding Previous German-Language Media Activities
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- As a result of a review by the British Columbia Securities Commission (the “BCSC”), Beyond Oil Ltd. (CSE: BOIL; OTCQB: BEOLF; Frankfurt: UH9) (“Beyond Oil” or the “Company”) today …

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …

CBL International Limited Announces Share Repurchase Program Repurchase Reflects the Board’s Confidence in Long-Term Growth
Kuala Lumpur, Malaysia, June 03, 2025 (GLOBE NEWSWIRE) -- CBL International Limited (NASDAQ: BANL) (the “Company” or “CBL”), the listing vehicle of Banle Group (“Banle” or “the Group”), today announced that its Board of Directors has authorized a share …

HeartCore Signs 15th Go IPO Contract
NEW YORK and TOKYO, June 03, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and data consulting services company based in Tokyo, announced that it has signed an agreement (“ …

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
ROCKVILLE, MD, June 03, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …

Green Bay Packaging Invests More Than $1 Billion in Morrilton, Arkansas Facility
MORRILTON, Ark., June 03, 2025 (GLOBE NEWSWIRE) -- Green Bay Packaging, a leading manufacturer of innovative packaging solutions, is expanding its existing manufacturing facility in Morrilton, Arkansas, with an investment of more than $1 billion. This …

IGEL übernimmt Stratodesk: Mehr Reichweite und mehr Kompetenz im sicheren Endpoint Computing
FORT LAUDERDALE, Florida, June 03, 2025 (GLOBE NEWSWIRE) -- IGEL, die sichere Endpoint-OS-Plattform für SaaS, DaaS, VDI und sichere Enterprise-Browser, gibt heute die Übernahme von Stratodesk bekannt – einem renommierten Anbieter von Betriebssystem- und …

Innventure to Participate in Upcoming Investor Conferences
ORLANDO, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), a technology commercialization platform, today announced its participation at the following investor conferences: June 12, 2025 – Lucas Harper, Chief Investment …

Carbon Revolution Announces Receipt of Non-Compliance Letter from Nasdaq
GEELONG, Australia, June 03, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that …

Microchip Technology to Present at the Bank of America 2025 Global Technology Conference
CHANDLER, Ariz., June 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Bank of America 2025 …

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
KUALA LUMPUR, MALAYSIA, June 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has received …

NevGold Adds More Significant Oxide Gold-Antimony Results: 1.47 g/t AuEq Over 74.7 Meters (0.23% Antimony And 0.45 g/t Au), Including 3.59 g/t AuEq Over 18.2 Meters (0.60% Antimony And 0.92 g/t Au), and Also Including 4.61 g/t AuEq Over 6.0 Meters…
Vancouver, British Columbia, June 03, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has discovered further significant oxide gold-antimony (“Antimony”, “Sb”) …